Table 2 Association with pathological stage of CRC patients with lower MTUS1 expression
From: MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer
Characteristics | Total(N) | Odds Ratio(OR) forMTUS1 expression | P value |
|---|---|---|---|
Gender (Male vs. Female) | 644 | 0.809 (0.593-1.102) | 0.180 |
Age (>65 vs. <=65) | 644 | 0.904 (0.661-1.235) | 0.524 |
T stage (T3&T4 vs. T1&T2) | 641 | 1.047 (0.713-1.539) | 0.815 |
N stage (N1&N2 vs. N0) | 640 | 0.653 (0.476-0.895) | 0.008 |
M stage (M1 vs. M0) | 564 | 0.668 (0.418-1.055) | 0.086 |
Pathologic stage (Stage III & Stage IV vs. Stage I & Stage II) | 623 | 0.626 (0.454-0.860) | 0.004 |
CEA level (>5 vs. <=5) | 415 | 0.886 (0.594-1.320) | 0.552 |
Neoplasm type (READ vs. COAD) | 644 | 0.699 (0.489-0.996) | 0.048 |